Clinical Trials in Caen, Normandy
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
NSCLC
Regeneron Pharmaceuticals231 enrolled40 locationsNCT04077099
Recruiting
Phase 1Phase 2
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Endometrial CancerRecurrent Ovarian CancerLow Grade Serous Ovarian Cancer+3 more
Regeneron Pharmaceuticals890 enrolled51 locationsNCT03564340
Recruiting
Phase 1Phase 2
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Regeneron Pharmaceuticals612 enrolled24 locationsNCT04590326
Recruiting
Not Applicable
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
Lung Cancer
University Hospital, Rouen184 enrolled3 locationsNCT06202222
Recruiting
Phase 2
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Wayshine Biopharm, Inc.40 enrolled18 locationsNCT06868485
Recruiting
Atrial Fibrillation in Active Cancer Patients
CancerAtrial FibrillationCardiovascular Complication+1 more
University Hospital, Caen1,000 enrolled1 locationNCT04696081
Recruiting
Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry
Atrial FibrillationLone Atrial Fibrillation
University Hospital, Caen200 enrolled1 locationNCT04776759